Novartis Investigative Site

Almelo, Overijssel 7609 PP

0 studies enrolling now · 2 studies all time

What they study most

Polymyalgia Rheumatica

Studies at this site

• Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) — Running, not enrolling
• Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) — Completed